Search Result "Janus kinase 2 (JAK2)"
JAK2-mediated Intracellular Signaling
Journal: Current Molecular Medicine
Volume: 21 Issue: 5 Year: 2021 Page: 417-425
Author(s): Mentor Sopjani,Rifat Morina,Valdet Uka,Nguyen Thi Xuan,Miribane Dërmaku-Sopjani
QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 15 Issue: 2 Year: 2018 Page: 169-180
Author(s): Basheerulla Shaik,Satya P. Gupta,Tabassum Zafar,K. Anita
The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 546-555
Author(s): Nilda L. Alicea-Velazquez, Titus J. Boggon
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
The Relevance of JAK2 in the Regulation of Cellular Transport
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 6 Year: 2016 Page: 578-588
Author(s): Mentor Sopjani,Vjollca Konjufca,Mark Rinnerthaler,Rexhep Rexhepaj,Miribane Dërmaku-Sopjani
Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2017 Page: 268-294
Author(s): Eleni Vrontaki,Georgia Melagraki,Antreas Afantitis,Thomas Mavromoustakos,George Kollias
Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 7 Year: 2014 Page: 638-651
Author(s): Marcin Mielecki,MaÅgorzata Milner-Krawczyk,Krystyna Grzelak,Damian Mielecki,Krystiana A. Krzysko,Bogdan Lesyng,Waldemar Priebe
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitorfor the Treatment of Atopic Dermatitis
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 38 Year: 2023 Page: 4278-4282
Author(s): Surya K. De
Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 18 Year: 2019 Page: 1531-1543
Author(s): Jun Dai,LiXi Yang,Glynn Addison